Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

  • Pharma
  • February 12, 2025
  • 364 views
Astrazeneca Pharma gains after Q3 PAT soars to Rs 55 cr

Astrazeneca Pharma India advanced 1.21% to Rs 7557.05 after the company’s standalone net profit surged to Rs 54.68 crore in Q3 FY 25 as compared with Rs 15.80 crore in…

  • Pharma
  • January 2, 2025
  • 186 views
Kwality Pharma gains on securing RCGM approval for Erythropoietin

Kwality Pharmaceuticals rose 3.19% to Rs 895 after the company secured approval from the Review Committee on Genetic Manipulation (RCGM) to begin pre-clinical toxicity studies for the recombinant Erythropoietin product,…